InsidersTradesSigma
Browse the full directors' dealings record of Keenova Therapeutics plc, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 4 June 2026 (Levée d'options). Among the most active insiders: Bisaro Paul. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Keenova Therapeutics plc is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker KOVA.